Pamela J. Mink, Ph.D., M.P.H.

Dr. Mink has experience in the design, analysis, and interpretation of epidemiologic studies. Much of her research has focused on hormonally related cancers in women and men. In particular, she has evaluated the roles of hormone replacement therapy, exercise, obesity, and diet in cancer and other major causes of morbidity and mortality. She has also reviewed, both qualitatively and quantitatively (i.e., meta-analysis), epidemiologic studies on occupational and environmental exposures and health-related outcomes. In addition, she has conducted analyses of potential sources of bias in studies of low-level environmental exposures and neurobehavioral test performance in children.

Dr. Mink has more than fifteen years of training and experience in analyzing and interpreting data from large cohort studies and national data sets. In addition, she developed and implemented a protocol for ascertaining cancer cases in a multi-center cohort study, and designed and implemented a nested case-control study within this cohort. She has also analyzed data from a cross-sectional study of physicians and patients in a large midwestern health plan to evaluate factors contributing to cancer screening of female patients.

In addition to her training and experience in epidemiology, Dr. Mink completed two years of graduate coursework and research in cognitive psychology, and two additional years of experience as a research assistant on studies of human memory and cognition. She has also been an adjunct professor and taught an introductory epidemiology course at the Georgetown Public Policy Institute in Washington, DC. Prior to joining Exponent, Dr. Mink was a Cancer Prevention Fellow at the National Cancer Institute. She has participated on the faculty of the National Cancer Institute’s Summer Curriculum, giving lectures summarizing the literature and ongoing studies regarding the epidemiology, prevention, and control of ovarian cancer, and on the analysis and interpretation of data from epidemiologic studies. Dr. Mink is currently a faculty member of the Rollins School of Public Health, Emory University, Atlanta, Georgia.

Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort. Ann Epidemiol, in press.

Teta MJ, Mink PJ, Sceurman BS, Foster ED. U.S. Mesothelioma Patterns 1973–2002: Indicators of change and insights into background rates. Eur J Cancer Prev, in press.

Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR Jr, Scrafford CG, Barraj LM, Mink PJ, Robien K. Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer 2008; 123:664–671.

Mink PJ, Adami H-O, Trichopoulos D, Britton NL, Mandel JS. Pesticides and prostate cancer: A review of epidemiologic studies with specific agricultural exposure information. Eur J Cancer Prev 2008; 17:97–110.

Mandel JH, Kelsh M, Mink PJ, Alexander DD. Trichloroethylene exposure and non-Hodgkin's lymphoma: supportive evidence [letter/response]. Occup Environ Med. 2008; 65:147–148.

Goodman M, Mink PJ, Barraj LM, Britton NL, Yager JW, Flanders WD, Kelsh MA. Estimating uncertainty in observational studies of environmental exposures and neuropsychological testing in children: Example of methylmercury. Epidemiol Perspect Innov 2007; Sep 26;4(1):9 [Epub ahead of print].

Alexander DD, Kelsh MA, Mink PJ, Mandel JH, Basu R, Weingart M. A meta-analysis of occupational trichloroethylene exposure and liver cancer. Int Arch Occup Environ Health 2007; 81:127–43.

Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D. The non-Hodgkin lymphomas: A review of the epidemiologic literature. Int J Cancer 2007; 120 Suppl 12:1–39.

Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D. Multiple myeloma: A review of the epidemiologic literature. Int J Cancer 2007; 120 Suppl 12:40–61.

Tsuji JS, Yost LJ, Barraj LM, Scrafford CG, Mink PJ. Use of background inorganic arsenic exposures to provide perspective on risk assessment results. Regul Toxicol Pharmacol 2007; 48:59–68.

Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am J Clin Nutr 2007; 85:895–909.

Nettleton JA, Harnack LJ, Scrafford CG, Mink PJ, Barraj LM, Jacobs DR Jr. Dietary flavonoids and flavonoid-rich foods are not associated with risk of type 2 diabetes in postmenopausal women. J Nutr 2006; 136:3039–45.

Alexander D, Mink PJ, Mandel JH, Kelsh MA. A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukemia. Occup Med 2006; 56:485–493.

Kazerouni N, Greene MH, Lacey JV Jr, Mink PJ, Schairer C. Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. Cancer 2006; 107:1075-83.

Mandel JH, Kelsh M, Mink PJ, Alexander DD, Kalmes R, Weingart M, Yost L, Goodman M. Occupational trichloroethylene occupational trichloroethylene exposure and non-Hodgkin's lymphoma: A review and meta-analysis. Occup Environ Med 2006; 63:597–607.

Tsuji JS, Van Kerkhove MD, Kaetzel RS, Scrafford CG, Mink PJ, Barraj LM, Crecelius EA, Goodman M. Evaluation of exposure to arsenic in residential soil. Environ Health Perspect 2005; 113:1735–1740.

Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B. Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease. J Occup Environ Med 2005; 47:1059–1087.

Purdue MP, Mink PJ, Hartge P, Huang WY, Buys S, Hayes RB. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Cancer Causes Control 2005; 16:965–973.

Teta MJ, Tran NL, Mink PJ, Barraj LM. Validity of using background leukemia incidence rates with cohort mortality-based potency estimates to calculate excess lifetime risk. Human and Ecological Risk Assessment 2004; 10:923–938.

Schairer C, Mink PJ, Carroll L, Devesa SS. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 2004; 96:1311–1321.

Mink PJ, Goodman M, Barraj LM, Imrey H, Kelsh MA, Yager J. Evaluation of uncontrolled confounding in studies of environmental exposures and neurobehavioral testing in children. Epidemiology 2004; 15:385–393.

Hessel PA, Kalmes R, Smith TJ, Lau E, Mink PJ, Mandel J. A nested case-control study of prostate cancer and atrazine exposure. J Occup Environ Med 2004; 46:379–385.

Thyagarajan B, Brott M, Mink P, Folsom AR, Anderson KE, Oetting WS, Gross M. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Lett 2004; 207:183–189.

Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, Devesa S. Survival among women with borderline ovarian tumors and ovarian carcinoma: A population-based analysis. Cancer 2004; 100:1045–1052.

Boland LL, Mink PJ, Bushhouse SA, Folsom AR. Weight and length at birth and risk of early onset prostate cancer (United States). Cancer Causes Control 2003; 14:335–338.

Mink PJ, Folsom AR. Two of the authors reply. [letter/response]. Am J Epidemiol 2003; 158:608.

Mink PJ, Sherman ME, Devesa SS. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998. Cancer 2002; 95:2380-2389.

Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR. Serum insulin and glucose levels and breast cancer incidence: The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2002; 156:349-352.

Lacey JV, Mink PJ, Lubin JH, Sherman ME, Troisi RJ, Hartge P, Schatzkin A, Schairer C. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002; 288:334-341.

Weed DL, Mink PJ. Roles and responsibilities of epidemiologists. Ann Epidemiol 2002; 12:67–72.

Vachon CM, Mink PJ, Janney CA, Cerhan JR, Sellers TA, Folsom AR. Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women. Epidemiology 2002; 13:66–71.

Anderson KE, Anderson E, Mink PJ, Hong C-P, Kushi LH, Sellers TA, Lazovich D, Folsom AR. Diabetes and endometrial cancer in the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev 2001; 10:611-616.

Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong C-P, Sellers TA, Lazovich D, Prineas RJ. Associations of general and abdominal obesity with multiple health outcomes in older women: The Iowa Women’s Health Study. Arch Intern Med 2000; 160:2117-2128.

Moore DB, Folsom AR, Mink PJ, Hong C-P, Anderson KE, Kushi LH. Physical activity and incidence of postmenopausal breast cancer: The Iowa Women’s Health Study. Epidemiology 2000; 11:292-296.

Lazovich D, Thompson JA, Mink PJ, Sellers TA, Anderson KE. Induced abortion and breast cancer risk. Epidemiology 2000; 11:76–80.

Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, Sellers TA. A prospective study of diet and ovarian cancer. Am J Epidemiol 1999; 149:21–31.

Pemberton AG, Margolis K, Mink P, McGovern P, Lurie N. Women’s preferences for specialists who provide cancer screening and general medical care. J Gen Intern Med 1998; 13:624–626.

Lurie N, Margolis K, McGovern P, Mink P. Physician self-report of comfort and skill in providing preventive care to patients of the opposite sex. Arch Fam Med 1998; 7:134–137.

Sellers TA, Mink PJ, Cerhan JR, Zheng W, Anderson KE, Kushi LH, Folsom, AR. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Ann Intern Med 1997; 127:973–980.

Kushi LH, Fee RM, Folsom AR, Mink PJ, Anderson KE, Sellers TA. Physical activity and mortality in postmenopausal women. JAMA 1997; 277:1287–1292.

French SA, Folsom AR, Jeffery RW, Zheng W, Mink PJ, Baxter JE. Weight variability and incident disease in older women: The Iowa Women’s Health Study. Int J Obes 1997; 21:217-223.

Lurie N, Margolis K, McGovern P, Mink P, Slater J. Why do patients of female physicians have higher rates of breast and cervical cancer screening? J Gen Intern Med 1997; 12:34–43.

Kushi LH, Mink PJ, Folsom AR. Re: Antioxidant vitamins, cancer, and cardiovascular disease. [letter/response]. N Engl J Med 1996; 335:1068.

Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease. N Engl J Med 1996; 334:1156–1162.

Mink PJ, Folsom AR, Sellers TA, Kushi LH. Physical activity, waist-hip ratio and other risk factors for ovarian cancer: A prospective study of older women. Epidemiol 1995; 7:38–45.

Folsom AR, Mink PJ, Sellers TA, Hong C-P, Zheng W, and Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Pub Health 1995; 85:1128–1132.

Presentations

Mink P. Invited speaker and panelist. 5th Annual Cancer Prevention Fellows’ Scientific Symposium: Cancer Prevention and Control: The Next Generation. National Cancer Institute, Bethesda, MD, September 13, 2006.

Mink P. Considerations for the analysis and interpretation of epidemiologic data. Lecture presented to students in the Principles and Practice of Cancer Prevention and Control Course, NCI Summer Curriculum in Cancer Prevention, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, July 10, 2006.

Mink P, Alexander D, Barraj L, Kelsh M, Tsuji J. Meta-analysis of low level arsenic exposure and bladder cancer. Poster presentation at the 2nd North American Congress of Epidemiology, Seattle, WA, June 21–24, 2006.

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. Meta-analysis of low level arsenic exposure and bladder cancer: Implications for risk assessment in the United States. Poster presentation at the 45th Annual Meeting of the Society of Toxicology, San Diego, CA, March 5–9, 2006.

Mink P. Using epidemiologic data to estimate cancer risk: A review and meta-analysis of low-level arsenic exposure in drinking water and bladder cancer. Presentation to the EPA Science Advisory Board Arsenic Review Panel, Washington, DC, September 12, 2005.

Mink P, Scrafford C, Harnack L, Barraj L, Hong C-P, Jacobs D. Flavonoid intake and cardiovascular disease mortality: A prospective study of postmenopausal women. Poster presentation at the 2nd International Conference on Polyphenols and Health, Davis, CA, October 4–7, 2005.

Mink P. Epidemiologic studies of atrazine and breast/ovarian cancers in women. Presentation at conference, Atrazine and the Health of Humans and Wildlife: State of the Science and Future Research Needs, Iowa City, IA, April 25, 2005.

Mink P. Pesticides science and safety: A literature review and evaluation of the OCFP (Ontario College of Family Physicians) report on pesticides. An invited presentation at the Ontario Parks Association Meeting, Hamilton, Ontario, Canada, March, 2005.

Mink P. Methodologic approaches to evaluating potential biases in epidemiologic studies. An invited presentation in the Cancer Prevention and Control Colloquia Series, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, October 29, 2004.

Mink P. Pesticide science and safety. An invited presentation at CropLife Canada 2004 Conference, Montreal, Quebec, September, 2004.

Li AA, Mink PJ, McIntosh L, Teta MJ, Finley B. Evaluation of epidemiological and animal data associating pesticides with Parkinson’s disease. Poster presentation at the 43rd Annual Meeting of the Society of Toxicology, Baltimore, MD, March, 2004.

Teta MJ, Tran N, Mink P. Validity of excess lifetime risk estimation using background leukemia incidence rates with cohort mortality-based exposure-response curves. Platform presentation at the Society for Risk Analysis Annual Meeting, Baltimore, MD, December, 2003.

Mink PJ, Goodman M, Barraj L, Imrey H, Kelsh M, Yager J. Evaluation of uncontrolled confounding in studies of environmental exposures and neurobehavioral testing in children. Poster presentation at the 36th Annual Meeting of the Society for Epidemiologic Research, Atlanta, GA, June, 2003.

Mink PJ, Hayes RB, Huang W-Y, Pinsky P, Buys S, Hartge P. Hormone replacement therapy, reproductive history, and colorectal adenomas: Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Poster presentation at the 16th World Congress of Epidemiology, International Epidemiological Association, Montreal, Quebec, August, 2002.

Mink P. Epidemiology, prevention and control of ovarian cancer. Lecture presented to students in the Principles and Practice of Cancer Prevention and Control Course, NCI Summer Curriculum in Cancer Prevention, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, July 15, 2002.

Mink P. The epidemiology of ovarian cancer: Differences by histopathologic subtype. Seminar presentation to the Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, February 18, 2002. Seminar presentation to the Department of Epidemiology and Preventive Medicine, University of Maryland, Baltimore, MD, January 28, 2002.

Mink P. Epidemiology, prevention and control of ovarian cancer. Lecture presented to students in the Principles and Practice of Cancer Prevention and Control Course, NCI Summer Curriculum in Cancer Prevention, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, July 17, 2001.

Mink PJ, Shahar E, Rosamond W, Alberg A, Folsom AR. Plasma lipid levels and breast cancer risk. Poster presentation at the Congress of Epidemiology, Toronto, Ontario, June 2001.

Mink PJ, Shahar E, Rosamond W, Alberg A, Folsom AR. Abdominal obesity, serum insulin and glucose levels and breast cancer incidence. Poster presentation at the 25th Annual Meeting of the American Society of Preventive Oncology, New York, NY, March 2001.

Mink P. Epidemiologic research on ovarian cancer: Current challenges and future directions. Seminar presentation to the Division of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, March 1, 2001.

Mink P. Epidemiologic research on ovarian cancer. Presentation to the Ovarian Cancer National Alliance, National Institutes of Health, Bethesda, MD, June 9, 2000.

Mink P, Kushi L, Sellers T, Zheng W, Folsom A. Dietary risk factors for ovarian cancer: A prospective study of older women. Poster presentation at the 29th Annual Meeting of the Society for Epidemiologic Research, Boston, MA, June 1996.

Mink P, Folsom A, Sellers T, Kushi L. Physical activity, waist-to-hip ratio and other risk factors for ovarian cancer: A prospective study of older women. Platform presentation at the 28th Annual Meeting of the Society for Epidemiologic Research, Snowbird, Utah, June 1995.

• National Cancer Institute, Cancer Prevention Fellow, 1999–2002

• Society for Epidemiologic Research (member)
• American Society for Preventive Oncology (member)